156 related articles for article (PubMed ID: 21515043)
21. [Fibrates - the present state of art].
Krysiak R; Rudzki H; Handzlik-Orlik G; Gdula-Dymek A; Okopień B
Pol Merkur Lekarski; 2016 Jun; 40(240):341-4. PubMed ID: 27403898
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity.
Chen ZH; Zheng CJ; Sun LP; Piao HR
Eur J Med Chem; 2010 Dec; 45(12):5739-43. PubMed ID: 20889240
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
[TBL] [Abstract][Full Text] [Related]
24. Antidyslipidemic activity of polyprenol from Coccinia grandis in high-fat diet-fed hamster model.
Singh G; Gupta P; Rawat P; Puri A; Bhatia G; Maurya R
Phytomedicine; 2007 Dec; 14(12):792-8. PubMed ID: 17689941
[TBL] [Abstract][Full Text] [Related]
25. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis.
Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R
Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558
[TBL] [Abstract][Full Text] [Related]
26. PPAR-α agonists are still on the rise: an update on clinical and experimental findings.
Ferri N; Corsini A; Sirtori C; Ruscica M
Expert Opin Investig Drugs; 2017 May; 26(5):593-602. PubMed ID: 28343425
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.
Pandeti S; Sonkar R; Shukla A; Bhatia G; Tadigoppula N
Eur J Med Chem; 2013 Nov; 69():439-48. PubMed ID: 24090915
[TBL] [Abstract][Full Text] [Related]
28. Influence of chalcone analogues on serum glucose levels in hyperglycemic rats.
Alberton EH; Damazio RG; Cazarolli LH; Chiaradia LD; Leal PC; Nunes RJ; Yunes RA; Silva FR
Chem Biol Interact; 2008 Feb; 171(3):355-62. PubMed ID: 18164698
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological evaluation of novel benzoylazole-based PPAR α/γ activators.
Ushiroda K; Maruta K; Takazawa T; Nagano T; Taiji M; Kohno T; Sato Y; Horai S; Yanagi K; Nagata R
Bioorg Med Chem Lett; 2011 Apr; 21(7):1978-82. PubMed ID: 21377875
[TBL] [Abstract][Full Text] [Related]
30. Novel keto-enamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2H-benzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents.
Sashidhara KV; Rosaiah JN; Bhatia G; Saxena JK
Eur J Med Chem; 2008 Nov; 43(11):2592-6. PubMed ID: 18063225
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of potent and subtype-selective PPARalpha agonists.
Desai RC; Metzger E; Santini C; Meinke PT; Heck JV; Berger JP; MacNaul KL; Cai TQ; Wright SD; Agrawal A; Moller DE; Sahoo SP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1673-8. PubMed ID: 16384704
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and hypolipidemic activity of novel 2-(4-(2-amino-6-(4-substituted phenyl) pyrimidin-4-yl)-2-substituted phenoxy) acetic acid derivatives.
Mokale SN; Shete MT; Shaikh SI; Shinde DB
Chem Biol Drug Des; 2012 Apr; 79(4):548-52. PubMed ID: 22226122
[TBL] [Abstract][Full Text] [Related]
33. Discovery and identification of 2-phenylethyl 2,6-dihydroxybenzoate as a natural lipid-lowering lead.
Luo Y; Li G; Li G; Yan J; Yi J; Zhang G
Planta Med; 2011 Dec; 77(18):2047-9. PubMed ID: 21858759
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents.
Abdel-Aziz AA; El-Azab AS; Attia SM; Al-Obaid AM; Al-Omar MA; El-Subbagh HI
Eur J Med Chem; 2011 Sep; 46(9):4324-9. PubMed ID: 21783284
[TBL] [Abstract][Full Text] [Related]
35. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
Preiss D
Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
[No Abstract] [Full Text] [Related]
36. Coumarin chalcone fibrates: a new structural class of lipid lowering agents.
Sashidhara KV; Palnati GR; Sonkar R; Avula SR; Awasthi C; Bhatia G
Eur J Med Chem; 2013 Jun; 64():422-31. PubMed ID: 23665798
[TBL] [Abstract][Full Text] [Related]
37. Antidyslipidemic activity of furano-flavonoids isolated from Indigofera tinctoria.
Narender T; Khaliq T; Puri A; Chander R
Bioorg Med Chem Lett; 2006 Jul; 16(13):3411-4. PubMed ID: 16644212
[TBL] [Abstract][Full Text] [Related]
38. Design of more potent squalene synthase inhibitors with multiple activities.
Kourounakis AP; Matralis AN; Nikitakis A
Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243
[TBL] [Abstract][Full Text] [Related]
39. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4.
Kerr DJ; Hamel E; Jung MK; Flynn BL
Bioorg Med Chem; 2007 May; 15(9):3290-8. PubMed ID: 17360188
[TBL] [Abstract][Full Text] [Related]
40. Pyranocoumarins: a new class of anti-hyperglycemic and anti-dyslipidemic agents.
Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Bhatia G; Srivastava AK
Bioorg Med Chem Lett; 2009 Nov; 19(22):6447-51. PubMed ID: 19811915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
